CTI BIOPHARMA CORP: accounts_receivable
| Value | {"amount": 15387000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2022-12-31) |
| Status | current |
| Entity | CTI BIOPHARMA CORP |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:57:46.154821+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/8a71dbaf-fe1d-4138-aa4d-ba4b3ac67546
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000891293-23-000011 · Open the official SEC filing →Retrieved: 2026-08-19T08:57:46.154821+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000891293/accounts-receivable/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/8a71dbaf-fe1d-4138-aa4d-ba4b3ac67546
History
- no predecessors — first report